Pancreatic Cancer Genetics

Abroad (travel likely)Recruiting

Conditions

Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Columbia University Medical Center, New York, New York, United States
Contact: Study coordinator (Fay Kastrinos, MD) · fk18@columbia.edu · 212-305-1021
Contact: Study coordinator (Vilma Rosario) · vr2222@columbia.edu · 212-305-6033
Contact: Principal Investigator (Fay Kastrinos, MD)

Study leads

Fay Kastrinos, MD
Principal Investigator
Columbia University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases

Unresectable Pancreatic Cancer · Advanced Pancreatic Cancer · Lymph Node Metastases

Abroad (travel likely)RecruitingPHASE1

Zhengzhou, China · Suzhou, China

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer)

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Boston, United States

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

Pancreatic Cancer · Retroperitoneal Pain Syndrome

Abroad (travel likely)RecruitingPHASE1

Cleveland, United States

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer Metastatic

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China